Literature DB >> 1330568

Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain.

U Gullberg1, M Lantz, L Lindvall, I Olsson, A Himmler.   

Abstract

Soluble forms of receptors for tumor necrosis factor (TNF) might be important for regulating the actions of TNF. Site-directed in vitro mutagenesis was employed to examine the processing of the p55 tumor necrosis factor receptor chain (TNF-R55) into soluble TNF-binding protein (TNF-R55-BP). An Asn/Val sequence close to the transmembrane region in TNF-R55 was indicated as a putative cleavage site for proteolytic processing. By mutagenesis, Asn and Val were replaced with Gly and Ala, respectively. Expression in Chinese hamster ovary (CHO) cells resulted in identical binding of ligand to mutated receptors as compared to receptors not subjected to mutagenesis. Turnover rates of receptors as judged by disappearance of TNF binding capacity after inhibition of de novo protein synthesis and downregulation in response to incubation with phorbol esters were also identical between wild-type and mutated receptors. However, mutations of the cleavage site resulted in a decreased spontaneous and phorbol ester-induced release of soluble receptor (TNF-R55-BP) which was almost abolished when both Asn and Val were mutated. Our results clearly demonstrate the importance of an Asn/Val sequence for proteolytic processing of the TNF-R55 into soluble TNF-R55-BP and indicate that phorbol ester-induced downregulation of the TNF-R55 may be dissociated from proteolytic cleavage of the receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330568

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  8 in total

1.  Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation.

Authors:  C M Smas; L Chen; H S Sul
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 2.  Membrane protein secretases.

Authors:  N M Hooper; E H Karran; A J Turner
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

3.  Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.

Authors:  J Reiland; V L Ott; C S Lebakken; C Yeaman; J McCarthy; A C Rapraeger
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.

Authors:  L M Williams; D L Gibbons; A Gearing; R N Maini; M Feldmann; F M Brennan
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Inhibitors of collagenase but not of gelatinase reduce cartilage explant proteoglycan breakdown despite only low levels of matrix metalloproteinase activity.

Authors:  C J Brown; S Rahman; A C Morton; C L Beauchamp; H Bramwell; D J Buttle
Journal:  Clin Mol Pathol       Date:  1996-12

6.  Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.

Authors:  H Redl; G Schlag; G R Adolf; B Natmessnig; J Davies
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.

Authors:  P Ettehadi; M W Greaves; D Wallach; D Aderka; R D Camp
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

8.  A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Authors:  P D Crowe; B N Walter; K M Mohler; C Otten-Evans; R A Black; C F Ware
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.